Breaking News, Promotions & Moves

Kincell Bio Promotes Lawrence Pitcher to CEO

Pitcher offers experience scaling cell and gene therapy manufacturing operations and aligning them with client and patient needs.

Author Image

By: Charlie Sternberg

Associate Editor

Lawrence “Larry” Pitcher.

Kincell Bio, a contract development and manufacturing organization (CDMO) in cell therapy, has promoted Lawrence “Larry” Pitcher to Chief Executive Officer, effective immediately. Pitcher succeeds Mark R. Bamforth OBE, who guided the company through a successful phase of growth as CEO and will continue to support the transition in a strategic capacity as Executive Chair of the Board. “Larry has a proven track record scaling cell and gene therapy manufacturing operations and aligning them w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters